Regulator Ban Could Lead to Silimed Implant Compensation Claims

The ban on sales of Silimed silicone implants could result in Silimed implant compensation claims if contamination found in Brazil is also found in Europe.

Earlier today, it was reported by Reuters that the Medicines and Healthcare Products Regulatory Agency (MHRA) has suspended sales of Silimend silicone implants following the discovery of contamination in the company´s Rio de Janeiro manufacturing plant.

The MHRA and other European regulators are testing products already in Europe to determine whether the contamination is a recent event or if has affected the quality of implants already shipped from Brazil. The MHRA has advised the UK healthcare industry not to use Silimed implants until further notice.

The suspension of Silimed implant sales comes five years after French authorities discovered that Poly Implant Prothèse (PIP) was not using medical-grade silicone in its breast implants – a discovery that led to the closure of the company and a jail sentence for its president, Jean-Claude Mas, in 2013.

The MHRA´s suspension of Silimed sales may ultimately be unfounded, but the regulator is taking no chances after being criticised by the Commons Health Committee in 2012 for failings in the way that the PIP breast implant scandal was handled and for a lack of communication.

No Evidence Yet to Support Silimed Implant Compensation Claims

As the investigation into possible contamination is only a few hours old, there is no evidence yet to support Silimed implant compensation claims. The MHRA is advising people who have concerns about their Silimed implants is to contact their implanting surgeon or clinic.

According to the manufacturers, any potential health issues will be limited to the European Union; for, although products manufactured by Silimed are also sold under license in the US by Sientra Inc, an ongoing clinical trial in the US has yet to disclose any problems with the implants.

People who have already been diagnosed with an injury or a health condition due to a Silimed implant should speak with a solicitor about making Silimed implant compensation claims. Your solicitor will be able to advise you of the latest situation regarding the MHRA´s suspension of Silimed sales and the ongoing investigation into the safety of the implants.